This topic contains a solution. Click here to go to the answer

Author Question: A nurse researcher should be concerned about establishing clear eligibility criteria for inclusion ... (Read 91 times)

piesebel

  • Hero Member
  • *****
  • Posts: 565
A nurse researcher should be concerned about establishing clear eligibility criteria for inclusion in a study sample because such criteria will do what?
 
  a. Increase the homogeneity of the sample
  b. Decrease the homogeneity of the sample
  c. Increase the size of the sample
  d. Decrease the size of the sample

Question 2

What can a nurse researcher use to restrict the study population to homogeneous groups of subjects?
 
  a. Sampling
  b. Self-selection
  c. Eligibility criteria
  d. Defining study limitations



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

enass

  • Sr. Member
  • ****
  • Posts: 380
Answer to Question 1

ANS: A

Feedback
A Clear eligibility criteria are designed to increase the homogeneity of the sample.
B Clear eligibility would not hinder homogeneity but support it.
C Eligibility criteria do not directly increase or decrease sample size.
D Eligibility criteria do not directly increase or decrease sample size.

Answer to Question 2

ANS: C

Feedback
A Sampling does not mandate restricting the population to a homogeneous group of subjects.
B Self-selection would not restrict subjects to a homogeneous group.
C Eligibility criteria restrict or control the homogeneity of subjects in relation to the population.
D Specifying study limitations would not restrict subjects to homogeneity.





 

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Historic treatments for rheumatoid arthritis have included gold salts, acupuncture, a diet consisting of apples or rhubarb, nutmeg, nettles, bee venom, bracelets made of copper, prayer, rest, tooth extractions, fasting, honey, vitamins, insulin, snow collected on Christmas, magnets, and electric convulsion therapy.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

For a complete list of videos, visit our video library